Mazdutide
Typical Dosage
2.5-10 mg
Administration
Injection
Half-Life
Long-acting; roughly supports once-weekly dosing
Mechanism of Action
Obesity and diabetes trials|GLP-1/glucagon dual-agonist pharmacology|Weight-loss research|NAFLD/metabolic disease studies
Research Protocol Summary
Evidence Level
Human Clinical / Investigational
Typical Protocol Duration
Long-term Chronic Weekly Treatment In Trials
Species Studied
Human • Mouse • Rat
Administration Schedule
Once Weekly
Studies
Research Availability
Individual PubMed records have not been mapped for this entry yet. Use the linked PubMed search to review the current literature directly.
Related resources
Research Feedback
0 approved
For research discussion only. Community feedback is moderated and shown here as aggregated insights after approval.
Loading approved insights…